Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal Injections

This publication has 23 references indexed in Scilit:

• Incidence and clinical features of post-injection endophthalmitis according to diagnosis
  British Journal of Ophthalmology, 2015
• Effect of a Strict ‘No-Talking’ Policy During Intravitreal Injection on Post-Injection Endophthalmitis
  Ophthalmic Surgery, Lasers and Imaging Retina, 2015
• Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome
  American Journal of Ophthalmology, 2015
• Conjunctival Flora Antibiotic Resistance Patterns After Serial Intravitreal Injections Without Postinjection Topical Antibiotics
  American Journal of Ophthalmology, 2014
• Meta-Analysis of Infectious Endophthalmitis After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
  Ophthalmic Surgery, Lasers and Imaging Retina, 2014
• The Role of Topical Antibiotic Prophylaxis to Prevent Endophthalmitis after Intravitreal Injection
  Ophthalmology, 2014
• Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
  Eye, 2013
• Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates
  British Journal of Ophthalmology, 2013
• Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
  Ophthalmology, 2011
• META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS
  Retina, 2011